Ticker: PRPH

ProPhase Labs, Inc. (NASDAQ: PRPH) - concise operating & income-statement snapshot Quick take: - Company pivoting from diagnostics/manufacturing to genomics, consumer products and diagnostics IP (BE‑Smart™, Equivir, Linebacker). - Major corporate moves in H1 2025: sale of Pharmaloz/PMI (closed Ja...

ProPhase Labs, Inc. (NASDAQ: PRPH) Q1 2025 Overview ProPhase Labs, Inc. reported its quarterly financial results for the period ending March 31, 2025. The company specializes in diagnostics and consumer products, including genomics testing and dietary supplements. Here’s a summary of the key find...